MedPath

Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer

Phase 2
Completed
Conditions
Cancer of the Prostate
Prostate Cancer
Prostatic Neoplasms
Interventions
Dietary Supplement: Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin E
Drug: Placebo
Registration Number
NCT00844792
Lead Sponsor
University Health Network, Toronto
Brief Summary

The purpose of this study is to see if an intervention of antioxidants(vitamin E, selenium and lycopene) can change (reduce) prostate tumor size and alter certain markers that can affect tumor growth and prostate cancer aggressiveness.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
48
Inclusion Criteria
  • Diagnosis of a Gleason score > or = to 7 adenocarcinoma of the prostate
  • At least 30% of one core involved
  • Radical prostatectomy planned
  • Willingness to discontinue use of supplements at least 4 weeks prior to study intervention (for subjects using vitamin E, selenium or lycopene at time of consent)
  • ability and willingness to consume study intervention for 6 - 8 weeks prior to radical prostatectomy.
Read More
Exclusion Criteria
  • Previous treatment for prostate cancer
  • Current use of finasteride or dutasteride
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin EThis group of men will be on active treatment (antioxidants)for 6-8 weeks prior to their radical prostatectomy.
2PlaceboThis group of men will be on placebo for 6-8 weeks prior to their radical prostatectomy.
Primary Outcome Measures
NameTimeMethod
To determine the impact of combination Vitamin E, Selenium and Lycopene on prostate tumor size and to study certain markers in blood and prostate tissue which affect prostate tumor growth or shrinkage.Blood samples will be collected prior to intervention and 8 weeks later , prior to surgery. Prostate tissue will be harvested at time of surgery, after the prostate has been removed.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Health Network, Princess Margaret Hospital

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath